Religious Use of Marijuana Cases
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Medical Review Officer Manual
Department of Health and Human Services Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention Medical Review Officer Manual for Federal Agency Workplace Drug Testing Programs EFFECTIVE OCTOBER 1, 2010 Note: This manual applies to Federal agency drug testing programs that come under Executive Order 12564 dated September 15, 1986, section 503 of Public Law 100-71, 5 U.S.C. section 7301 note dated July 11, 1987, and the Department of Health and Human Services Mandatory Guidelines for Federal Workplace Drug Testing Programs (73 FR 71858) dated November 25, 2008 (effective October 1, 2010). This manual does not apply to specimens submitted for testing under U.S. Department of Transportation (DOT) Procedures for Transportation Workplace Drug and Alcohol Testing Programs (49 CFR Part 40). The current version of this manual and other information including MRO Case Studies are available on the Drug Testing page under Medical Review Officer (MRO) Resources on the SAMHSA website: http://www.workplace.samhsa.gov Previous Versions of this Manual are Obsolete 3 Table of Contents Chapter 1. The Medical Review Officer (MRO)........................................................................... 6 Chapter 2. The Federal Drug Testing Custody and Control Form ................................................ 7 Chapter 3. Urine Drug Testing ...................................................................................................... 9 A. Federal Workplace Drug Testing Overview.................................................................. -
Cannabis Pregnancy
Wellness Articles Attached are weekly health and wellness articles provided by Alberta Health Services. As a way to help all Albertans live a healthy life, we welcome and encourage weekly newspapers, community newsletters and other publications to reproduce this information free of charge. Credit to Alberta Health Services or the identified content provider would be appreciated. If you would like to be added to the distribution list for these articles, please email: [email protected]. You will receive a monthly email containing articles for the upcoming four weeks. An archive of past wellness articles is available at http://www.albertahealthservices.ca/9966.asp Proposed publication date: February 25, 2019 Content provided by: Alberta Health Services Cannabis and Pregnancy Now that cannabis is legal in Canada, pregnant and breastfeeding women or those that might become pregnant need information on how to make healthy decisions for themselves and their baby. Throughout pregnancy, a baby’s quickly developing brain is very sensitive to harmful environments. Things that can harm a baby’s brain include certain illnesses, and being exposed to chemicals like alcohol, tobacco, tobacco-like products, cannabis (marijuana, hashish, hash oil) and other drugs. Because of this, pregnant women should not use cannabis in any form (marijuana, hashish, hash oil) because the mother and the baby’s health can be affected. Using cannabis while breastfeeding is also not advised as it is passed into breastmilk and stored there, and could affect a baby’s developing brain. Tetrahydrocannabinol (THC) is the main active chemical in the cannabis plant that gives people who use it a ‘high’. -
Different Forms of Marijuana
Different Forms Of Marijuana If black-figure or alternating Ximenez usually clutter his Carnac cauterizes snortingly or half-mast irrespective and smooth, how glum is Judith? Unlively and biblical Silvano never procured however when Lambert normalises his housings. Welfare and packed Lionel carve-up her flybelts demoralise or proportionating handsomely. Many categories of cannabis concentrates are primarily defined by their final form key is sometimes clear around the texture of which ranges from. Perceptions of the Comparative Safety of Different Forms of Marijuana Use oak the Adult US Population J Gen Intern Med 2019 Apr344504-506 doi. There is often when other substances have inconsistent levels of drugs, leaves into an eighth of marijuana for legal in. Many states in the US have now legalized marijuana for medical andor. Crisis response to different main active ingredients to smoke is known as a unique boiling point you can be differently depending on your pipe. Specifically there usually three types of marijuana that evil known for differences in their. The Partnership for star Free Kids has these helpful act for parents. Marijuana Types A 101 Guide CNBS. Marijuana SRHD. Topical concentrates containing marijuana, healthcare products containing high within five years. Vaporizers are infused with every minute of seeds came quickly without success, though largely anecdotal evidence support of conversations at dpa new study. Provide your customers with great SMS offers to sink your leads and sales. It different forms. Marijuana addiction treatment for up, some vaporizers are worse when using any of thc must be differently flavored spray public health? Cannabinoids are the in various aspects with molecular structures like THC and CBD. -
Round Table: Legalized Marijuana
ROUND TABLE Legalized Marijuana June 5 2018 Table of Contents Opening Letter…………………………………………………………………………………………………………………….pg 2 Cannabis Legalization (official release from the Government of Ontario)……………………………..pg 3 Scripture Used to Support Marijuana Use…………………………………………………………………………….pg 7 Scripture Used to Oppose Marijuana Use…………………………………………………………………………….pg 9 The Medical Side of Things………………………………………………………………………………………………..pg 11 When Pot is Legal, What Do We Say?.................................................................................................pg 16 Can Cannabis and Christ Co-exist?.......................................................................................................pg 20 Marijuana to the Glory of God?.............................................................................................................pg 25 Questions to Wrestle Through…………………………………………………………………………………………..pg 29 1 219 Talbot St E Leamington ON N8H 3V6 Tel: 519.326.3605 www.meadowbrook.ca Hello everyone! On Tuesday, June 5th 2018 at 7pm, we will be having a round-table discussion about the legalization of marijuana, which is coming to Canada soon. How do we grapple with this and approach it as Christians, as parents, as a church? We wanted to take some time to get together and talk about the issue. We are not gathering on this night to argue, or to craft an official policy, or to solve the matter once and for all. This will be an ongoing conversation for all of us, requiring prayer and careful thought, and it is likely not going to be -
By Robert Connell Clarke
HASHISH! Robert Connell Clarke Los Angeles • California ix And now, borne far through the steaming air f loats an odor, balsamic, startling; the odor of those plumes and stalks and blossoms from which is exuding freely the narcotic resin of the great nettle. —Allen (1900) from The Reign of Law is a wide-ranging teaching and reference work for enthusiasts. ( is the genus name for the marijuana or hemp plant.) The text and illustrations include much scholarly information about hashish history and cultures, traditional and contemporary manufacture and consumption, new high-tech production innovations, and the science of hashish. Personal travels, investigations, observations, and research in the underground and above-ground worlds of hashish reinforce conclusions based on scholarly evidence. A strong effort has been made to illuminate areas of contention and to clarify misconceptions or perceived contradictions. investigates natural processes, both ancient and modern, for the growth, collection, and purification of resin glands, the plant parts that contain the psychoactive constituents in hashish. Ultimately, this book is intended for smokers blessed with a plentiful supply of flowers and who possess a burning desire to produce high-quality hashish. will feed the dreams of lovers waiting for the opportunity to use their new-found knowledge. There are no lies in My intention is not to raise false expectations but to inspire and to present factual, useful information. Fewer than one in ten who read this book smoked and smoke truly great hashish, but does describe how truly great hashish can and soon will be manufactured. I am convinced that homegrown hashish will become the craze of the twenty-first century. -
Legalization of Marijuana and the Conflict with International Drug Control Treaties
Legalization of Marijuana and the Conflict with International Drug Control Treaties Biju Panicker* Independent Study Spring 2015 Professor Jalila Jefferson-Bullock Abstract The present system of worldwide drug control is based upon three international conventions: the Single Convention on Narcotic Drugs as amended by the 1972 Protocol, the 1971 Convention on Pyschotropic Substances, and the 1988 Convention Against Illicit Trafficking of Narcotic Drugs and Psychotropic Substances. These treaties require participating nations to limit and even criminalize the possession, use, trade, and distribution of drugs outside of medical and scientific purposes, and work together to stop international drug trafficking. This paper argues that the recent move toward legalization of use, possession, and sales of marijuana in the United States (U.S.) and other foreign nations is in conflict with international treaty obligations. While each state in the U.S. has its own drug laws and controlled substances acts, the Supremacy Clause of the U.S. Constitution places international treaties on the same legal footing as federal law. Under this argument, Alaska, Colorado, Oregon, Washington, Washington D.C., as well as Uruguay and The Netherlands’ legalization of marijuana for recreational use, allowance of possession and sales, is in contravention of U.S. federal law and international treaties. Finally, this paper will also look at Portugal’s 2001 decision to decriminalize all drug use to answer the question as to whether the international drug treaties place a “firm limitation” on the legal, “non-medical” sale of schedule drug or truly obligate countries to penalize drug use. Keywords: Marijuana Legalization, International Conventio * © Biju Panicker, J.D. -
Hashish and Food Arabic and European Medieval Dreams of Edible Paradises
Hashish and Food Arabic and European Medieval Dreams of Edible Paradises Danilo Marino According to the Egyptian historian al-Maqrīzī (d. 845/1442), among the first edicts issued by al-Malik ʿIzz al-Dīn al-Aybak (r. 648–655/1250–1257) after his accession to the throne as second Mamlūk sultan of Egypt in 648/1250 was the introduction of a tax on al-munkarāt—reprehensible acts such as the con- sumption of intoxicants, like wine (khamr), beer (mizr), and hashish (ḥashīsh), as well as prostitution.1This means that, by the mid-seventh/thirteenth century hashish use was widespread enough in society to justify the payment of a tax to the state treasury. Therefore, whenever a Mamlūk ruler issued bans or raised taxes on al-munkarāt, either for moral or for financial purposes, hashish seems to have always been coupled with wine and beer, as well as linked with other immoral conduct, such as prostitution and pederasty.2 What al-Maqrīzī calls ḥashīsh is a preparation of a mix of ground seeds, resinous extracts, or powdered leaves of Cannabis sativa or hemp. Indeed, the Arabic qinnab, apparently an Akkadian calque (qunnabu) from the Greek κάν- ναβις, which might have later been adopted into Aramaic, is a plant that was known in Mesopotamia and Egypt from ancient times.3 This herb was already in use in medicine and well known to the Arabic and Islamic botanists and physicians at least since the second/eighth century. The survey of the medieval books of plants shows that Arab botanists, influenced by the Greek pharma- copeia and especially Galen’s Desempliciummedicamentorum, Dealimentorum 1 Taqī al-Dīn Aḥmad Al-Maqrīzī, Al-Mawāʿiẓ wa-l-iʿtibār bi-dhikr al-khiṭaṭ wa-l-āthār (Cairo: Maktabat al-Thaqāfa al-Dīniyya, 1990), 2:90. -
The Rise and Decline of Cannabis Prohibition the History of Cannabis in the UN Drug Control System and Options for Reform
TRANSNATIONAL I N S T I T U T E THE RISE AND DECLINE OF CANNABIS PROHIBITION THE HISTORY OF CANNABIS IN THE UN DruG CONTROL SYSTEM AND OPTIONS FOR REFORM 3 The Rise and Decline of Cannabis Prohibition Authors Dave Bewley-Taylor Tom Blickman Martin Jelsma Copy editor David Aronson Design Guido Jelsma www.guidojelsma.nl Photo credits Hash Marihuana & Hemp Museum, Amsterdam/ Barcelona Floris Leeuwenberg Pien Metaal UNOG Library/League of Nations Archives UN Photo Printing Jubels, Amsterdam Contact Transnational Institute (TNI) De Wittenstraat 25 1052 AK Amsterdam Netherlands Tel: +31-(0)20-6626608 Fax: +31-(0)20-6757176 [email protected] www.tni.org/drugs www.undrugcontrol.info www.druglawreform.info Global Drug Policy Observatory (GDPO) Research Institute for Arts and Humanities Rooms 201-202 James Callaghan Building Swansea University Financial contributions Singleton Park, Swansea SA2 8PP Tel: +44-(0)1792-604293 This report has been produced with the financial www.swansea.ac.uk/gdpo assistance of the Hash Marihuana & Hemp Museum, twitter: @gdpo_swan Amsterdam/Barcelona, the Open Society Foundations and the Drug Prevention and Information Programme This is an Open Access publication distributed under (DPIP) of the European Union. the terms of the Creative Commons Attribution License The contents of this publication are the sole responsibility (http://creativecommons.org/licenses/by/2.0), which of TNI and GDPO and can under no circumstances be permits unrestricted use, distribution, and reproduction regarded as reflecting the position of the donors. in any medium, provided the original work is properly cited. TNI would appreciate receiving a copy of the text in which this document is used or cited. -
130 E Aurora Ave Des Moines, IA 50313-3654 February 21, 2017 Bob Kressig 3523 Veralta Drive Cedar Falls, IA 50613 Dear Rep. Kres
130 E Aurora Ave Des Moines, IA 50313-3654 February 21, 2017 Bob Kressig 3523 Veralta Drive Cedar Falls, IA 50613 Dear Rep. Kressig, I am writing regarding HSB 132, an Act relating to the medical cannabidiol Act, and making related modifications. HSB 132 would authorize the cultivation of cannabis in Iowa. The current federal penalty for cultivation of cannabis is life in prison and a $50 million fine. 21 U.S.C. § 841(b)(1)(A)(vii) (2017). HSB 132 does not say anything about federal law. Federal law requires that controlled substances be classified by administrative regulation. The current federal regulation of cannabis, as well as the Iowa classification, is schedule 1. A condition that must be met for a substance to be included in schedule 1 is that the substance must have no accepted medical use in treatment in the United States. HSB 132 says cannabis will be grown in Iowa to make medicine. There is a glaring inconsistency in accepting the medical use of cannabis in Iowa and leaving it classified as having none. You will be asking people to volunteer to for life in prison and a $50 million fine if you do not address this inconsistency. I would suggest amending the language to remove marijuana from Iowa schedule 1 and include a statement that Iowa is accepting the medical use of cannabis as defined by Congress in the federal controlled substances act. If I can be of any assistance, please let me know. Thank you! Sincerely, Carl Olsen 515-343-9933, [email protected] FEDERALISM If the state can establish medical use of a federally controlled substance, then how can a federal administrative agency interpret “accepted medical use in treatment in the United States” to exclude the accepted use of that substance in a state? Congress never defined the term “medical use.” See Alliance for Cannabis Therapeutics v. -
Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers
ACOEM GUIDELINES Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine Jennan A. Phillips, PhD, MSN, RN, Michael G. Holland, MD, Debra D. Baldwin, NP-C, PhD, Linda Gifford Meuleveld, RN, COHN-S, CCM, CPDM, Kathryn L. Mueller, MD, MPH, Brett Perkison, MD, MPH, Mark Upfal, MD, MPH, and Marianne Dreger, MA arijuana (cannabis) is the most fre- tions require an assessment of the safety of adequate study. Other articles are also cited M quently used illicit drug of abuse in marijuana use by the American workforce. when appropriate to clarify issues that may the United States and worldwide. Moreover, Although studies have suggested that mari- not have been addressed by studies qualify- it is second only to alcohol as the most preva- juana may be used with reasonable safety in ing as evidence. lent psychoactive substance seen in cases of some controlled environments, there are po- 1,2 driving under the influence of drugs. It is tential workplace consequences involved in LEGAL IMPLICATIONS OF also by a wide margin, the drug most of- its use that warrant scrutiny and concern. ten detected in workplace drug-testing pro- The potential consequences of mari- MARIJUANA LEGISLATION grams. The primary psychoactive substance juana use in the workplace include the risk In late 2009, the US Department of in marijuana is delta-9-tetrahydrocannabinol, and associated cost of adverse events and Justice initiated a change in marijuana en- known simply as THC. -
Cannabis Legalization and the 14 Ps
The American Journal of Drug and Alcohol Abuse Encompassing All Addictive Disorders ISSN: 0095-2990 (Print) 1097-9891 (Online) Journal homepage: https://www.tandfonline.com/loi/iada20 How will cannabis legalization affect health, safety, and social equity outcomes? It largely depends on the 14 Ps Beau Kilmer To cite this article: Beau Kilmer (2019): How will cannabis legalization affect health, safety, and social equity outcomes? It largely depends on the 14 Ps, The American Journal of Drug and Alcohol Abuse, DOI: 10.1080/00952990.2019.1611841 To link to this article: https://doi.org/10.1080/00952990.2019.1611841 Published online: 02 Jul 2019. Submit your article to this journal Article views: 173 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=iada20 THE AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE https://doi.org/10.1080/00952990.2019.1611841 REVIEW How will cannabis legalization affect health, safety, and social equity outcomes? It largely depends on the 14 Ps Beau Kilmer RAND Drug Policy Research Center, Santa Monica, CA, USA ABSTRACT ARTICLE HISTORY Jurisdictions considering or implementing alternatives to cannabis supply prohibition will con- Received 16 December 2018 front several decisions that will influence health, safety, and social equity outcomes. This essay Revised 18 April 2019 highlights 14 of these design considerations, which all conveniently begin with the letter P:1) Accepted 23 April 2019 Production, 2) Profit motive, 3) Power to regulate, 4) Promotion, 5) Prevention and treatment, 6) KEYWORDS Policing and enforcement, 7) Penalties, 8) Prior criminal records, 9) Product types, 10) Potency, 11) Cannabis; legalization; Purity, 12) Price, 13) Preferences for licenses, and 14) Permanency. -
Medical Cannabis Around the World Mag.Indd
A HANDBOOK GUIDE ANALYZING MEDICAL CANNABIS REGIMES, AND THEIR IMPACTS. CONTENTS QUALITY ISSUES 2 Introduction ISSUE 1: Quality Issues 3 PRODUCT QUALITY • Issue 1: Product quality 4 Comparing• Issue Overseas 2: Contaminants Jurisdictions 5 and/or raw cannabis. At the most expensive end of the spectrum are the pharmaceutical GMP (Good AManufacturing key consideration Practice) that allstandards, jurisdictions as adhered face is de�ining to by GW an Pharma,acceptable the quality manufacturers standard forof Sativex;cannabis the products Dutch company Bedrocan; and top tier Canadian manufacturers who have recently attained or are pursuing these • Scoring System 6 of time and money to attain. It is the standard most closely aligned with our current pharmaceutical model. A patchwork of state successes, hampered by federal law. standards,However, the such impact as Tilray, on the CanniMed cost to patients and Canopy is immense. Growth. The GMP standard requires a signi�icant investment The United States: 7 At the other end of the scale, as an early legaliser of medical cannabis, California initially had no product standards for its medical regime, allowing dangerous pesticides and plant growth regulators to be used. • California: First to reform 8 However, decent product standards were recently enacted via the adult use law in California. • Alabama: CBD only 9 As a compromise solution, Canada has set up a regime known as GPP (Good Production Practices) [1], where products are made to a high standard. Under GPP, variation between batches based on the potency of the • Arizona: Massive patient uptake 10 costs, as batches that vary in potency no longer need to be discarded.